More than a quarter of adults aged 50 and over are vitamin D deficient, say researchers, who urge supplement uptake and a mandatory food fortification policy as most effective in tackling deficiencies.
Global omega-3 player KD Pharma says the new site at Seal Sands will expand its capacity for manufacturing omega-3-based intermediates, especially for those use in producing active pharmaceutical ingredients (APIs).
OptiBiotix Health continues the profitable drive of its Lactobacillus plantarum (LPLDL) probiotic strain in a license agreement with Nutrilinea for its use as a food supplement ingredient to help reduce high blood pressure.
Individualised nutrition not only helps patients consume more protein and calories, but also improves clinical treatment outcomes and reduces mortality rate, according to a Swiss study of more than 2,000 patients.
With ever-blurring lines between the food and pharmaceutical space, the NutraIngredients team asked experts at our recent Probiota conference how they believe the microbiome space will develop in the future.
Chr. Hansen applies its microbiome expertise in the pharma arena as the firm enters a collaboration with Lonza to produce live biotherapeutic (LBP) products that address a range of gastrointestinal and cardiovascular conditions.